Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cosmos Health Inc. (COSM)
USD0.29
-0.01 (-4.75%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
141 West Jackson Boulevard 60604
Chicago, IL, US
Chicago, IL, US
CEO
Grigorios Siokas
Website
cosmosholdingsinc.com
IPO
2010-07-23
CIK 1474167 ISIN US2214133058
Description
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.29
-0.01 (-4.75%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
4.12
Float Shares
39.52M
Free Float %
75.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.00% | -4.47% | -30.86% | -32.67% | -58.52% | -47.27% | -43.53% | -91.33% | -94.16% | -95.90% | -97.90% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.29
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-2.66
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+19.9% ★ Q1'26: +30.7% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+46.2% ★ Q1'26: -74.3% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-28.5% Q1'26: -6.0% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-25.3% Q1'26: -12.2% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-43.9% Q1'26: -23.1% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+58.2% Q1'26: +96.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-1.32× Q1'26: -2.52× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
53.38M
est: 51.29M (+4.1%)
|
54.43M
est: 54.70M (-0.5%)
|
65.27M
est: 64.40M (+1.4%)
|
87.30M
87.30M – 87.30M
+35.6% YoY
|
110.80M
110.80M – 110.80M
+26.9% YoY
|
| EBITDA |
-17.06M
est: -7.60M (-124.5%)
|
-13.92M
est: -11.51M (-20.9%)
|
-15.15M
est: -13.55M (-11.8%)
|
-18.37M
-18.37M – -18.37M
-35.6% YoY
|
-23.32M
-23.32M – -23.32M
-26.9% YoY
|
| EBIT |
-17.68M
est: -8.15M (-117.0%)
|
-15.17M
est: -12.25M (-23.9%)
|
-16.52M
est: -14.42M (-14.6%)
|
-19.55M
-19.55M – -19.55M
-35.6% YoY
|
-24.81M
-24.81M – -24.81M
-26.9% YoY
|
| Net Income |
-18.54M
est: -12.25M (-51.3%)
|
-16.18M
est: -23.63M (+31.5%)
|
-19.14M
est: -10.30M (-85.9%)
|
302.9K
302.9K – 302.9K
+102.9% YoY
|
2.12M
2.12M – 2.12M
+600.0% YoY
|
| SGA |
25.57M
est: 13.07M (+95.6%)
|
12.09M
est: 16.74M (-27.8%)
|
22.55M
est: 19.71M (+14.4%)
|
26.72M
26.72M – 26.72M
+35.6% YoY
|
33.91M
33.91M – 33.91M
+26.9% YoY
|
| EPS |
-2.15
est: -0.64 (-235.9%)
|
-1.17
est: -0.78 (-50.0%)
|
-0.63
est: -0.34 (-85.3%)
|
0.01
0.01 – 0.01
+102.9% YoY
|
0.07
0.07 – 0.07
+600.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-9.26M
OE per share TTM
-0.30
Owner's Yield
-74.86%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
11.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
21
Total invested
466.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
9
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dimitrios Goulielmos | 100.02M | 79.96% | — | 100.42M | — | 10.00 | IN | Greece | 2013-10-04 | ↗ |
| 2 | Athanasios Kolefas | 15.56M | 16.49% | 15.56M | — | 15.56M | — | IN | United States | 2022-11-04 | ↗ |
| 3 | Grigorios Siokas | 11.90M | 39.20% | 11.90M | — | 11.90M | — | IN | — | 2022-08-04 | ↗ |
| 4 | Panagiotis Drakopoulos | 6.32M | 44.63% | — | 10.94M | — | 10.94M | IN | Greece | 2011-06-23 | ↗ |
| 5 | Vasileios Mavrogiannis | 6.32M | 44.63% | — | 10.94M | — | 10.94M | IN | Greece | 2011-06-23 | ↗ |
| 6 | Armistice Capital, LLC | 1.50M | 9.99% | — | 1.50M | — | — | IA, OO | Delaware | 2024-02-14 | ↗ |
| 7 | Steven Boyd | 1.50M | 9.99% | — | 1.50M | — | — | HC, IN | United States of America | 2024-02-14 | ↗ |
| 8 | Hudson Bay Capital Management LP | 858.4K | 4.72% | — | 858.4K | — | — | PN | State of Delaware | 2022-02-04 | ↗ |
| 9 | Sander Gerber | 858.4K | 4.72% | — | 858.4K | — | — | IN | United States | 2022-02-04 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
21
-2 vs prev Q
New positions
4
Closed positions
6
Increased
10
Reduced
4
Put/Call ratio
0.00
Calls held
296.3K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 334.6K +241.8K (+260.5%) | 166.6K +63.6K (+61.8%) | 1.09% +0.770 pp | 0.00% +0.000 pp | USD0.67 -25.4% | 2 qtrs — |
| 2 | BLACKROCK, INC. | 267.8K +— (+0.0%) | 133.4K -163.9K (-55.1%) | 0.87% -0.057 pp | 0.00% +0.000 pp | USD0.88 -43.2% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 235.7K +— (+0.0%) | 117.4K -144.3K (-55.1%) | 0.77% -0.050 pp | 0.00% +0.000 pp | USD1.37 -63.5% | 10 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 198.7K +— (+0.0%) | 99.0K -121.6K (-55.1%) | 0.65% -0.042 pp | 0.00% +0.000 pp | USD2.13 -76.5% | 12 qtrs — |
| 5 | CITADEL ADVISORS LLC | 123.2K -102.4K (-45.4%) | 61.3K -189.0K (-75.5%) | 0.40% -0.382 pp | 0.00% +0.000 pp | USD0.81 -38.3% | 3 qtrs — |
| 6 | XTX TOPCO LTD | 99.6K +34.1K (+52.1%) | 49.6K -23.1K (-31.8%) | 0.33% +0.098 pp | 0.00% -0.003 pp | USD0.65 -23.1% | 5 qtrs — |
| 7 | STATE STREET CORP | 45.2K +20.5K (+82.9%) | 22.5K -4.9K (-18.0%) | 0.15% +0.062 pp | 0.00% +0.000 pp | USD2.01 -75.1% | 12 qtrs — |
| 8 | TWO SIGMA SECURITIES, LLC | 36.3K +36.3K (+100.0%) | 18.1K +18.1K (+100.0%) | 0.12% +0.119 pp | 0.00% +0.003 pp | USD0.50 +0.0% | 6 qtrs — |
| 9 | HRT FINANCIAL LP | 25.7K +15.1K (+142.8%) | 12.0K +1.0K (+9.1%) | 0.08% +0.047 pp | 0.00% +0.000 pp | USD0.75 -33.3% | 2 qtrs — |
| 10 | NORTHERN TRUST CORP | 20.6K +— (+0.0%) | 10.2K -12.6K (-55.1%) | 0.07% -0.004 pp | 0.00% +0.000 pp | USD3.52 -85.8% | 12 qtrs — |
| 11 | JANE STREET GROUP, LLC | 13.1K +13.1K (+100.0%) | 6.5K +6.5K (+100.0%) | 0.04% +0.043 pp | 0.00% +0.000 pp | USD0.50 +0.0% | 1 qtrs NEW |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12.1K -8.4K (-40.8%) | 6.0K -16.7K (-73.4%) | 0.04% -0.032 pp | 0.00% +0.000 pp | USD1.11 -55.0% | 2 qtrs — |
| 13 | VIRTU FINANCIAL LLC | 10.7K -6.2K (-36.9%) | 5.0K -14.0K (-73.7%) | 0.03% -0.024 pp | 0.00% -0.001 pp | USD0.42 +19.0% | 5 qtrs — |
| 14 | SIMPLEX TRADING, LLC | 6.4K +4.6K (+267.6%) | 3.2K +2.2K (+217.4%) | 0.02% +0.015 pp | 0.00% +0.000 pp | USD0.66 -24.2% | 2 qtrs — |
| 15 | NATIONAL BANK OF CANADA /FI/ | 6.4K +— (+0.0%) | 3.1K -3.8K (-55.0%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD0.42 +19.0% | 3 qtrs — |
| 16 | UBS GROUP AG | 3.7K +3.4K (+1,592.1%) | 1.8K +1.6K (+658.3%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD0.52 -3.8% | 10 qtrs — |
| 17 | GROUP ONE TRADING, L.P. | 2.4K +— (+0.0%) | 1.2K -1.5K (-55.1%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.42 -64.8% | 11 qtrs — |
| 18 | JONES FINANCIAL COMPANIES LLLP | 2.0K +2.0K (+100.0%) | 996.00 +996.0 (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD0.50 +0.0% | 1 qtrs NEW |
| 19 | TOWER RESEARCH CAPITAL LLC (TRC) | 783.00 +783.0 (+100.0%) | 390.00 +390.0 (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD0.50 +0.0% | 10 qtrs — |
| 20 | BANK OF AMERICA CORP /DE/ | 191.00 +14.0 (+7.9%) | 95.00 -101.0 (-51.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.85 -41.2% | 7 qtrs — |
| 21 | SBI SECURITIES CO., LTD. | 112.00 +— (+0.0%) | 56.00 -68.0 (-54.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.66 -24.2% | 5 qtrs — |
| 22 | WELLS FARGO & COMPANY/MN | 40.00 +36.0 (+900.0%) | 20.00 +16.0 (+400.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.53 -5.7% | 2 qtrs — |
| 23 | ADVISOR GROUP HOLDINGS, INC. | — -2.8K (-100.0%) | — -2.2K (-100.0%) | 0.00% -0.010 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 24 | BARCLAYS PLC | — -48.0 (-100.0%) | — -53.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 25 | STONEX GROUP INC. | — -19.3K (-100.0%) | — -21.4K (-100.0%) | 0.00% -0.067 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 26 | FMR LLC | — -4.0K (-100.0%) | — -4.4K (-100.0%) | 0.00% -0.014 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 42.0K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
9
Sells
0
Shares acquired
2.15M
Shares disposed
—
Cash buys
9.00
Cash sales
—
Net activity
+2,145,143
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 388,532 | 0.37 | 145.0K | 8,861,914 | D | ↗ |
| 2026-02-11 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 291,262 | 0.41 | 120.0K | 8,473,382 | D | ↗ |
| 2026-01-23 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 90,325 | 0.50 | 45.0K | 8,182,120 | D | ↗ |
| 2026-01-20 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 353,321 | 0.50 | 175.0K | 8,091,795 | D | ↗ |
| 2026-01-14 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 493,495 | 0.45 | 220.0K | 7,738,474 | D | ↗ |
| 2026-01-12 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 113,185 | 0.50 | 57.0K | 7,244,979 | D | ↗ |
| 2026-01-08 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 156,190 | 0.52 | 81.0K | 7,131,794 | D | ↗ |
| 2026-01-07 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 124,880 | 0.52 | 65.0K | 6,975,604 | D | ↗ |
| 2026-01-06 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 133,953 | 0.54 | 72.0K | 6,850,724 | D | ↗ |
| 2025-12-19 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 88,314 | 0.49 | 43.0K | 6,716,771 | D | ↗ |
| 2025-12-15 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 168,472 | 0.42 | 70.0K | 6,628,457 | D | ↗ |
| 2025-11-28 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 76,360 | 0.64 | 49.0K | 6,459,985 | D | ↗ |
| 2025-11-25 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 55,732 | 0.63 | 35.0K | 6,383,625 | D | ↗ |
| 2025-11-21 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 56,080 | 0.68 | 38.0K | 6,327,893 | D | ↗ |
| 2025-11-20 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 51,315 | 0.62 | 32.0K | 6,271,813 | D | ↗ |
| 2025-11-19 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 61,614 | 0.65 | 40.0K | 6,220,498 | D | ↗ |
| 2025-05-23 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 34,004 | 0.45 | 15.2K | 6,158,884 | D | ↗ |
| 2025-05-22 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 141,825 | 0.44 | 62.8K | 6,124,880 | D | ↗ |
| 2025-05-21 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 174,172 | 0.47 | 82.0K | 5,983,055 | D | ↗ |
| 2025-05-20 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 147,563 | 0.45 | 66.0K | 5,808,883 | D | ↗ |
| 2025-05-19 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 79,254 | 0.43 | 34.0K | 5,661,320 | D | ↗ |
| 2025-04-24 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 254,618 | 0.40 | 102.0K | 5,582,066 | D | ↗ |
| 2025-04-23 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 205,000 | 0.40 | 82.0K | 5,150,214 | D | ↗ |
| 2025-04-22 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 175,000 | 0.36 | 63.0K | 4,945,214 | D | ↗ |
| 2025-04-21 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 654,912 | 0.32 | 208.0K | 4,770,214 | D | ↗ |
| 2025-03-04 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 85,714 | 0.53 | 45.0K | 4,115,302 | D | ↗ |
| 2025-03-03 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 132,572 | 0.49 | 65.0K | 4,029,588 | D | ↗ |
| 2025-02-24 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 354,296 | 0.56 | 200.0K | 3,897,016 | D | ↗ |
| 2025-01-30 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 51,414 | 0.66 | 34.0K | 4,255,103 | D | ↗ |
| 2025-01-22 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 38,900 | 0.77 | 30.0K | 4,203,689 | D | ↗ |
| 2025-01-17 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 29,158 | 0.86 | 25.0K | 4,164,789 | D | ↗ |
| 2025-01-16 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 47,904 | 0.84 | 40.0K | 4,135,631 | D | ↗ |
| 2025-01-15 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 62,500 | 0.80 | 50.0K | 4,087,727 | D | ↗ |
| 2025-01-14 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 87,247 | 0.69 | 60.0K | 4,025,227 | D | ↗ |
| 2025-01-13 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 163,666 | 0.61 | 100.0K | 3,937,980 | D | ↗ |
| 2024-12-31 | Ziegler Manfred | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Terzis Georgios | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Siokas Grigorios | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Hoidas John James | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Bhutawala Suhel | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Bardakis Nikolaos | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-31 | Aslidis Anastasios | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-20 | Terzis Georgios | Officer | P-Purchase | A | Common Stock, $.001 par value | 85,778 | 0.58 | 50.0K | 727,263 | D | ↗ |
| 2024-12-20 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 257,334 | 0.58 | 150.0K | 3,774,314 | D | ↗ |
| 2024-09-19 | Demetriades Demetrios G. | Director | — | — | Common Stock, $.001 par value | 0 | 0.00 | — | 20,000 | D | ↗ |
| 2024-02-16 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 | 60,000 | 0.83 | 49.8K | 1,394,597 | — | ↗ |
| 2023-12-22 | Aslidis Anastasios | Director | D-Return | D | Common Stock, $.001 par value | 200 | 1.46 | 292.64 | 20,000 | — | ↗ |
| 2023-10-24 | Terzis Georgios | Officer | A-Award | A | Common Stock, $.001 par value | 51,485 | 1.01 | 52.0K | 152,459 | — | ↗ |
| 2023-10-12 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 6,712 | 23.66 | 158.8K | 1,334,597 | — | ↗ |
| 2023-09-18 | Bhutawala Suhel | Director | — | D | Common Stock, $.001 par value | 0 | 0.00 | — | 5,000 | — | ↗ |
| 2023-07-20 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 181,451 | 2.48 | 450.0K | 1,327,885 | — | ↗ |
| 2023-06-06 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 4,474 | 23.92 | 107.0K | 1,146,434 | — | ↗ |
| 2023-04-27 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 4,474 | 24.64 | 110.2K | 1,141,960 | — | ↗ |
| 2023-04-21 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 4,474 | 24.49 | 109.6K | 1,137,486 | — | ↗ |
| 2023-04-07 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 2,238 | 24.37 | 54.5K | 1,133,012 | — | ↗ |
| 2023-04-03 | Ziegler Manfred | Director | A-Award | A | Common Stock, $.001 par value | 5,000 | 0.00 | 5.00 | 5,000 | — | ↗ |
| 2023-04-03 | Terzis Georgios | Officer | A-Award | A | Common Stock, $.001 par value | 100,000 | 0.00 | 100.00 | 100,974 | — | ↗ |
| 2023-04-03 | Ignatiades Pavlos | Officer | A-Award | A | Common Stock, $.001 par value | 5,000 | 0.00 | 5.00 | 5,000 | — | ↗ |
| 2023-04-03 | Hoidas John James | Director | A-Award | A | Common Stock, $.001 par value | 5,000 | 0.00 | 5.00 | 5,000 | — | ↗ |
| 2023-04-03 | Bardakis Nikolaos | Officer | A-Award | A | Common Stock, $.001 par value | 10,000 | 0.00 | 10.00 | 10,000 | — | ↗ |
| 2023-04-03 | Aslidis Anastasios | Director | A-Award | A | Common Stock, $.001 par value | 20,000 | 0.00 | 20.00 | 20,200 | — | ↗ |
| 2023-02-01 | Bardakis Nikolaos | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-19 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Warrants | 260,870 | 11.50 | 3.00M | 260,870 | D | ↗ |
| 2022-12-02 | Ziegler Manfred | Director | — | D | Common Stock, $.001 par value | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-02 | Siokas Grigorios | Director / Officer | C-Conversion | A | Common Stock, $.001 par value | 1,131,098 | 0.62 | 703.0K | 21,747,605 | — | ↗ |
| 2022-11-30 | Siokas Grigorios | Director / Officer | C-Conversion | A | Common Stock, $.001 par value | 481,079 | 0.62 | 299.0K | 20,616,507 | — | ↗ |
| 2022-11-28 | Siokas Grigorios | Director / Officer | P-Purchase | A | Common Stock, $.001 par value | 801,261 | 0.62 | 498.0K | 20,135,429 | — | ↗ |
| 2022-10-20 | Siokas Grigorios | Director / Officer | P-Purchase | A | Common Stock, $.001 par value | 12,500,000 | 0.12 | 1.50M | 19,334,168 | — | ↗ |
| 2022-06-15 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Series A Preferred | 1,500 | 0.62 | 932.25 | 2,413,438 | — | ↗ |
| 2022-04-28 | Aslidis Anastasios | Director | — | D | Common Stock | 0 | 0.00 | — | 5,000 | — | ↗ |
| 2021-12-31 | Terzis Georgios | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-08 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $.001 per share | 125,000 | 6.00 | 750.0K | 6,834,167 | — | ↗ |
| 2021-10-22 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 8,150 | 0.29 | 2.4K | 6,786,217 | — | ↗ |
| 2021-07-20 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 12,300 | 3.85 | 47.4K | 7,085,867 | — | ↗ |
| 2021-07-20 | GOLDSTEIN PETER | Director / 10% Owner | P-Purchase | A | Common Stock, $.001 par value | 100,000 | 0.00 | 100.00 | 157,100 | — | ↗ |
| 2021-07-19 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 208,333 | 6.00 | 1.25M | 7,324,517 | — | ↗ |
| 2021-07-13 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 166,667 | 6.00 | 1.00M | 7,116,184 | — | ↗ |
| 2021-06-23 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 500,000 | 6.00 | 3.00M | 6,949,517 | — | ↗ |
| 2021-06-17 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 392,000 | 0.31 | 121.5K | 6,619,517 | — | ↗ |
| 2021-04-27 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 13,000 | 3.85 | 50.1K | 7,044,017 | — | ↗ |
| 2021-01-20 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 42,500 | 0.28 | 11.9K | 7,657,049 | — | ↗ |
| 2020-12-31 | Hoidas John James | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-21 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 10,000 | 0.00 | 10.00 | 7,724,539 | — | ↗ |
| 2020-11-11 | Ignatiades Pavlos | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-10-19 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 7,100 | 0.00 | 28.40 | 7,734,539 | — | ↗ |
| 2020-10-15 | GOLDSTEIN PETER | Director | — | I | Common Stock, $.001 par value | 0 | 0.00 | — | 57,100 | — | ↗ |
| 2020-10-12 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 25,000 | 0.00 | 25.00 | 7,741,639 | — | ↗ |
| 2020-07-29 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 4,000 | 0.03 | 120.00 | 7,786,639 | — | ↗ |
| 2019-09-06 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 22,000 | 0.11 | 2.4K | 7,858,305 | — | ↗ |
| 2019-06-24 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 73,334 | 7.50 | 550.0K | 7,880,305 | — | ↗ |
| 2019-06-18 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 7,800 | 4.32 | 33.7K | 7,826,971 | — | ↗ |
| 2019-05-28 | Siokas Grigorios | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 66,667 | 7.50 | 500.0K | 8,036,971 | — | ↗ |
| 2019-02-27 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 10,400 | 0.11 | 1.1K | 7,997,304 | — | ↗ |
| 2018-12-31 | Siokas Grigorios | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-12-20 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 4,000 | 0.57 | 2.3K | 8,401,804 | — | ↗ |
| 2018-10-30 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 40,030 | 0.10 | 4.0K | 8,703,749 | — | ↗ |
| 2018-10-25 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 71,875 | 3.97 | 285.3K | 8,743,779 | — | ↗ |
| 2018-07-09 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 58,750 | 0.10 | 5.9K | 8,846,471 | — | ↗ |
| 2018-03-30 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 2,050 | 6.05 | 12.4K | 9,014,421 | — | ↗ |
| 2018-03-28 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 12,000 | 1.02 | 12.2K | 9,178,551 | — | ↗ |
| 2018-01-01 | Terzis Georgios | Officer | — | D | Common stock options | 25,000 | 1.00 | 25.0K | 0 | — | ↗ |
| 2017-12-13 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 5,800 | 0.90 | 5.2K | 9,272,151 | — | ↗ |
| 2017-10-23 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 120,000 | 0.49 | 58.8K | 94,406,213 | — | ↗ |
| 2017-10-16 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 21,000 | 0.08 | 1.8K | 94,756,213 | — | ↗ |
| 2017-05-31 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 25,000 | 0.04 | 1.1K | 95,306,133 | — | ↗ |
| 2017-04-05 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 24,000 | 0.04 | 1.0K | 97,295,933 | — | ↗ |
| 2017-03-02 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 297,000 | 0.03 | 8.9K | 97,735,933 | — | ↗ |
| 2017-03-01 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 295,400 | 0.01 | 3.0K | 98,032,933 | — | ↗ |
| 2017-02-08 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 135,000 | 0.04 | 5.4K | 99,102,666 | — | ↗ |
| 2017-02-06 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 140,000 | 0.07 | 9.7K | 99,237,666 | — | ↗ |
| 2017-01-17 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 700,000 | 0.03 | 21.0K | 99,804,666 | — | ↗ |
| 2016-11-18 | Hoidas John James | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-04 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 114,000 | 0.00 | 114.00 | 100,564,666 | — | ↗ |
| 2016-10-07 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 80,000 | 0.00 | 80.00 | 100,678,666 | — | ↗ |
| 2016-09-30 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 75,000 | 0.02 | 1.5K | 100,758,666 | — | ↗ |
| 2016-09-16 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 1,953,500 | 0.00 | 2.0K | 100,833,666 | — | ↗ |
| 2016-09-15 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 150,000 | 0.15 | 23.0K | 103,272,166 | — | ↗ |
| 2016-08-11 | Siokas Grigorios | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 137,500 | 0.40 | 55.0K | 103,579,166 | — | ↗ |
| 2016-01-11 | Siokas Grigorios | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 2,000,000 | 0.00 | — | 103,716,666 | — | ↗ |
| 2016-01-08 | Siokas Grigorios | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 2,400,000 | 0.00 | — | 101,716,666 | — | ↗ |
| 2015-11-04 | Siokas Grigorios | 10% Owner | — | D | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 95,000,000 | — | ↗ |
| 2015-11-04 | Goulielmos Dimitrios | Director / Officer | S-Sale | D | Common Stock, par value $0.001 per share | 95,000,000 | 1.00 | 95.00M | 5,416,000 | — | ↗ |
| 2013-09-27 | Goulielmos Dimitrios | Director / Officer / 10% Owner | — | D | Common Stock, par value $0.001 | 0 | 0.00 | — | 100,016,000 | — | ↗ |
| 2013-05-29 | MAVROGIANNIS VASILEIOS | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 | 675,000 | 0.02 | 10.1K | 9,700,227 | — | ↗ |
| 2013-05-29 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 266,667 | 0.04 | 10.7K | 8,758,561 | — | ↗ |
| 2013-05-15 | MAVROGIANNIS VASILEIOS | 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 50,000 | 0.04 | 2.0K | 9,025,227 | — | ↗ |
| 2013-04-09 | MAVROGIANNIS VASILEIOS | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 | 50,000 | 0.10 | 5.0K | 9,075,227 | — | ↗ |
| 2013-02-22 | MAVROGIANNIS VASILEIOS | 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 330,000 | 0.04 | 13.2K | 9,125,227 | — | ↗ |
| 2013-02-22 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 100,000 | 0.04 | 4.0K | 9,025,228 | — | ↗ |
| 2013-01-09 | MAVROGIANNIS VASILEIOS | 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 130,000 | 0.04 | 5.2K | 9,740,227 | — | ↗ |
| 2013-01-09 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 130,000 | 0.04 | 5.2K | 9,740,228 | — | ↗ |
| 2013-01-08 | MAVROGIANNIS VASILEIOS | 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 100,000 | 0.04 | 4.0K | 9,870,227 | — | ↗ |
| 2013-01-08 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 100,000 | 0.04 | 4.0K | 9,870,228 | — | ↗ |
| 2012-12-07 | MAVROGIANNIS VASILEIOS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 15,000 | 0.04 | 600.00 | 10,010,227 | — | ↗ |
| 2012-12-07 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 110,000 | 0.04 | 4.4K | 10,025,228 | — | ↗ |
| 2012-10-25 | MAVROGIANNIS VASILEIOS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 100,000 | 0.04 | 4.0K | 10,648,227 | — | ↗ |
| 2012-10-25 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 100,000 | 0.04 | 4.0K | 10,648,228 | — | ↗ |
| 2012-10-01 | MAVROGIANNIS VASILEIOS | Director / Officer / 10% Owner | S-Sale | D | Common Stock, par value $0.001 | 64,500 | 0.40 | 25.8K | 10,837,227 | — | ↗ |
| 2012-10-01 | DRAKOPOULOS PANAGIOTIS | Director / Officer | S-Sale | D | Common Stock, par value $0.001 | 29,000 | 0.34 | 9.9K | 10,748,228 | — | ↗ |
| 2012-09-01 | TOLIS PANAGIOTIS | Director / Officer | — | D | Common Stock, par value $0.40 | 0 | 0.00 | — | 196,250 | — | ↗ |
| 2011-06-14 | MAVROGIANNIS VASILEIOS | Director / Officer / 10% Owner | — | I | Common Stock, par value $.001 | 0 | 0.00 | — | 4,625,061 | — | ↗ |
| 2011-06-14 | DRAKOPOULOS PANAGIOTIS | Director / Officer / 10% Owner | — | D | Common Stock, par value $.001 | 0 | 0.00 | — | 6,316,667 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-110.9K
Shares Outstanding
52.33M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Grigorios Siokas | Chairman & Chief Executive Officer | 3M | male |
| Georgios Terzis | Chief Financial Officer | 348.2K | male |
| Nikolaos Bardakis | Chief Operating Officer | 39.4K | male |
| Demetrios G. Demetriades | Secretary & Independent Director | 15.0K | male |
| Dimitrios Trafalis | Head of Oncology | — | — |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COSM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
